DRD2 and Alzheimer disease: Yet another drug, rotigotine, a D2R- and D3R agonist, was able to show cognitive enhancement on probable AD patients, compared to their age-matched HCs by measuring the cortical excitability and central cholinergic transmission (Martorana et al., 2013).